Home>Topics>Companies>Bayer AG

Bayer AG

  1. All
  2. Commentary
  3. Stock Reports
  4. Fund Reports
  5. ETF Reports
  6. Headlines
  1. Spectrum Pharmaceuticals : A Long-Term Bet

    Headlines

    Thu, 28 Aug 2014

    By Samreen Agha : Spectrum Pharmaceuticals , Inc. ( SPPI ) is a small-cap biotechnology ..... with a number of companies, such as Hanmi Pharmaceuticals , Ligand Pharmaceuticals , Bayer , Biogen Idec, Mundipharma, TopoTarget

  2. Gilead: Let's Make A Deal

    Headlines

    Thu, 28 Aug 2014

    Gilead is now a larger company ($160 B market cap) than many familiar pharma names including Sanofi, Lilly, AbbVie, Bayer AG , Bristol-Myers-Squibb, GlaxoSmithKline, AstraZeneca, Novo Nordisk, and Amgen. Gilead is rapidly approaching the

  3. Why I Bought Into Monday's Move In Regeneron

    Headlines

    Tue, 26 Aug 2014

    major pharma company Sanofi (NYSE: SNY ). In addition to growth in ophthalmology, with which REGN partners with Bayer Healthcare , the greatest amount of pipeline excitement comes from the REGN injectable protein alirocumab. This is a cholesterol

  4. From Barron’s, August 25, 2014 (Part 1)

    Commentary

    Sat, 23 Aug 2014

    emerging-markets, reduced government budgets and increased R&D costs. For those wanting to buy, Novartis [ NVS ] and Bayer [ BAYN .ge/ BAYRY ] are attractive. Pg M7, Asia: Korean steel Posco [5490.sk/ PKX ] and Chinese car maker BYD [1211

  5. New Morningstar Analyst Report for Mallinckrodt PLC

    Stock Reports

    Wed, 13 Aug 2014

    Covidien, he was CEO of Bayer Healthcare 's U.S. pharmaceutical ..... experience at a firm like Bayer , which also has a broad ..... four segments: generic pharmaceuticals , branded pharmaceuticals , nuclear imaging, and

  6. New Morningstar Analyst Report for Merck KGaA

    Stock Reports

    Wed, 13 Aug 2014

    industry dating back to a 1982 financial position at Bayer , Kley has vast experience that should serve Merck well ..... the firm. Merck KGaA operates two main divisions, pharmaceuticals and chemicals. In the pharmaceutical group, branded

  7. Fitch Assigns Bayer AG's Hybrid Notes 'BBB+', 50% Equity Credit; Affirms IDR at 'A'

    Headlines

    Wed, 13 Aug 2014

    Fitch) Fitch Ratings has assigned Bayer AG 's EUR1.75bn and EUR1.5bn subordinated ..... rating of 'BBB+', two notches below Bayer 's Issuer Default Rating (IDR) of 'A ..... and pricing. Fitch has also affirmed Bayer 's IDR at 'A' wit

  8. EC approves Eylea label expansion

    Headlines

    Mon, 11 Aug 2014

    The European Commission approves Regeneron Pharmaceuticals ' (NASDAQ: REGN ) Eylea (aflibercept) for the treatment ..... following central retinal vein occulsion (CRVO). Partner Bayer ( OTCPK:BAYRY ) ( OTCPK:BAYZF ) plans to launch

  9. BRIEF- Bayer receives EU approval for Eylea in diabetic macular edema

    Headlines

    Mon, 11 Aug 2014

    Aug 11 (Reuters) - Bayer AG : * Says receives EU approval for Eylea in diabetic macular edema * Says plans for an immediate roll-out with Germany being one of the first

  10. New Morningstar Analyst Report for Bayer AG

    Stock Reports

    Wed, 30 Jul 2014

    declines in Betaseron, a top drug for Bayer .Both the material science and the ..... differentiation from the older version. Bayer is in the midst of launching several ..... drugs that hold blockbuster potential. Bayer 's strong entrenchment in biologics

« Prev12345Next »
Content Partners